Pharmaceutical Manufacturing Market Trend, Share, Growth, Size Analysis and Forecast 2032
Pharmaceutical Manufacturing Market - By Drug Type (Biologics & Biosimilars and Small Medicines), By Drug Development (In-house and Outsourced), By Formulation (Tablets, Injectables, Capsules, Sprays, Suspensions, and Powders), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 551.70 Billion | USD 1075.58 Billion | 7.7% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
- 2.2. Pharmaceutical Manufacturing Market: Snapshot
- Chapter 3. Global Pharmaceutical Manufacturing Market– Industry Analysis
- 3.1. Pharmaceutical Manufacturing Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Escalating demand for paperless and smart operations in drug production will scale up pharmaceutical manufacturing market growth.
- 3.2.2. Constant & seamless growth of personalized medicine market has led to exploration of patient-centric prototypes, thereby generating new growth opportunities for pharmaceutical manufacturing sector.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Drug Type
- 3.4.2. Market attractiveness analysis By Drug Development
- 3.4.3. Market attractiveness analysis By Formulation
- Chapter 4. Global Pharmaceutical Manufacturing Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Pharmaceutical Manufacturing Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Pharmaceutical Manufacturing Market– Drug Type Analysis
- 5.1. Global Pharmaceutical Manufacturing Market overview: By Drug Type
- 5.1.1. Global Pharmaceutical Manufacturing Market share, By Drug Type, 2020 and 2028
- 5.2. Biulogics & Biosimilars
- 5.2.1. Global Pharmaceutical Manufacturing Market by Biulogics & Biosimilars, 2018–2028(USD Billion)
- 5.3. Small Medicines
- 5.3.1. Global Pharmaceutical Manufacturing Market by Small Medicines, 2018–2028(USD Billion)
- 5.1. Global Pharmaceutical Manufacturing Market overview: By Drug Type
- Chapter 6. Global Pharmaceutical Manufacturing Market– Drug Development Analysis
- 6.1. Global Pharmaceutical Manufacturing Market overview: By Drug Development
- 6.1.1. Global Pharmaceutical Manufacturing Market share, By Drug Development, 2020 and 2028
- 6.2. In-house
- 6.2.1. Global Pharmaceutical Manufacturing Market by In-house , 2018–2028(USD Billion)
- 6.3. Outsourced
- 6.3.1. Global Pharmaceutical Manufacturing Market by Outsourced, 2018–2028(USD Billion)
- 6.1. Global Pharmaceutical Manufacturing Market overview: By Drug Development
- Chapter 7. Global Pharmaceutical Manufacturing Market– Formulation Analysis
- 7.1. Global Pharmaceutical Manufacturing Market overview: By Formulation
- 7.1.1. Global Pharmaceutical Manufacturing Market share, By Formulation, 2020 and 2028
- 7.2. Tablets
- 7.2.1. Global Pharmaceutical Manufacturing Market by Tablets , 2018–2028(USD Billion)
- 7.3. Injectables
- 7.3.1. Global Pharmaceutical Manufacturing Market by Injectables, 2018–2028(USD Billion)
- 7.4. Capsules
- 7.4.1. Global Pharmaceutical Manufacturing Market by Capsules, 2018–2028(USD Billion)
- 7.5. Sprays
- 7.5.1. Global Pharmaceutical Manufacturing Market by Sprays, 2018–2028(USD Billion)
- 7.6. Suspensions
- 7.6.1. Global Pharmaceutical Manufacturing Market by Suspensions, 2018–2028(USD Billion)
- 7.7. Powders
- 7.7.1. Global Pharmaceutical Manufacturing Market by Powders, 2018–2028(USD Billion)
- 7.1. Global Pharmaceutical Manufacturing Market overview: By Formulation
- Chapter 8. Company Profiles
- 8.1. Novartis AG
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Pfizer, Inc.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. AstraZeneca
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Development
- 8.4. Merck & Co., Inc.
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Development
- 8.5. Sanofi SA
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Johnson & Johnson
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Roche Hulding AG
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. AbbVie, Inc.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Eli Lilly and Company
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. Sun Pharmaceutical Industries Limited
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.11. Bristul Myers Squibb Company
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategy
- 8.11.5. Recent Development
- 8.12. Gilead Sciences, Inc.
- 8.12.1. Overview
- 8.12.2. Financials
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategy
- 8.12.5. Recent Development
- 8.13. Takeda Pharmaceuticals, Inc.
- 8.13.1. Overview
- 8.13.2. Financials
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategy
- 8.13.5. Recent Development
- 8.14. Novo Nordisk A/S
- 8.14.1. Overview
- 8.14.2. Financials
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategy
- 8.14.5. Recent Development
- 8.15. Cipla Limited
- 8.15.1. Overview
- 8.15.2. Financials
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategy
- 8.15.5. Recent Development
- 8.1. Novartis AG
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Pharmaceutical Manufacturing Marketattractiveness, By Drug Type
6. Global Pharmaceutical Manufacturing Marketattractiveness, By Drug Development
7. Global Pharmaceutical Manufacturing Marketshare by Drug Type ,2020 and 2028 (USD Billion)
8. Global Pharmaceutical Manufacturing Marketby Biologics & Biosimilars, 2018–2028(USD Billion)
9. Global Pharmaceutical Manufacturing Marketby Small Medicines, 2018–2028(USD Billion)
10. Global Pharmaceutical Manufacturing Marketshare by Drug Development ,2020 and 2028 (USD Billion)
11. Global Pharmaceutical Manufacturing Marketby In-house , 2018–2028(USD Billion)
12. Global Pharmaceutical Manufacturing Marketby Outsourced, 2018–2028(USD Billion)
13. Global Pharmaceutical Manufacturing Marketshare by Formulation ,2020 and 2028 (USD Billion)
14. Global Pharmaceutical Manufacturing Marketby Tablets, 2018–2028(USD Billion)
15. Global Pharmaceutical Manufacturing Marketby Injectables, 2018–2028(USD Billion)
16. Global Pharmaceutical Manufacturing Marketby Capsules, 2018–2028(USD Billion)
17. Global Pharmaceutical Manufacturing Marketby Sprays, 2018–2028(USD Billion)
18. Global Pharmaceutical Manufacturing Marketby Suspensions, , 2018–2028(USD Billion)
19. Global Pharmaceutical Manufacturing Marketby Powders, 2018–2028(USD Billion)
20. Global Pharmaceutical Manufacturing Marketshare, by Region, 2020 and 2028
21. North America Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
22. Europe Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
23. Asia Pacific Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
24. Latin America Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
25. The Middle East and Africa Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1. Global Pharmaceutical Manufacturing Market: snapshot
2. Drivers of the Pharmaceutical Manufacturing Market: impact analysis
3. North America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
4. North America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
5. North America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
6. The U.S. Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
7. The U.S. Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
8. The U.S. Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
9. Rest of North America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
10. Rest of North America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
11. Rest of North America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
12. Europe Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
13. Europe Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
14. Europe Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
15. UK Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
16. UK Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
17. UK Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
18. France Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
19. France Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
20. France Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
21. Germany Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
22. Germany Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
23. Germany Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
24. Rest of Europe Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
25. Rest of Europe Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
26. Rest of Europe Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
27. Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
28. Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
29. Asia Pacific Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
30. China Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
31. China Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
32. China Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
33. Japan Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
34. Japan Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
35. Japan Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
36. India Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
37. India Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
38. India Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
39. Rest of Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
40. Rest of Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
41. Rest of Asia Pacific Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
42. Latin America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
43. Latin America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
44. Latin America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
45. Brazil Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
46. Brazil Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
47. Brazil Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
48. Rest of Latin America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
49. Rest of Latin America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
50. Rest of Latin America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
51. The Middle East and Africa Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
52. The Middle East and Africa Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
53. The Middle East and Africa Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
54. Saudi Arabia Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
55. Saudi Arabia Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
56. Saudi Arabia Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
57. South Africa Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
58. South Africa Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
59. South Africa Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
Pharmaceutical manufacturing produces medicines at scale. It follows strict quality and safety standards
The global Pharmaceutical Manufacturing market is expected to be driven by the rising drug demand, generic production, and capacity expansion. Automation and compliance investments support expansion.
According to study, the global Pharmaceutical Manufacturing market size was worth around USD 551.70 Billion in 2023 and is predicted to grow to around USD 1075.58 Billion By 2032.
The global Pharmaceutical Manufacturing market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.7% during the forecast period from 2024-2032.
The global Pharmaceutical Manufacturing industry is projected to be challenged by Challenges include regulatory compliance, capacity constraints, and supply chain disruptions.
The Opportunities include generic and biologics growth, contract manufacturing, emerging market expansion, and automation adoption will offer significant growth opportunities in the Pharmaceutical Manufacturing market.
Continuous manufacturing and automation; digital twins and PAT integration; resilience and localization of supply chains are the emerging trends and innovations impacting the Pharmaceutical Manufacturing market.
The global Pharmaceutical Manufacturing market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Pharmaceutical Manufacturing market are; Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc., and Bristol Myers Squibb Company. and others.
The report explores crucial aspects of the Pharmaceutical Manufacturing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
